Quintin Pan

Title: Quintin Pan: Innovator in p53 Reactivation

Introduction

Quintin Pan is an accomplished inventor based in Dublin, OH (US). He has made significant contributions to the field of biochemistry, particularly in the area of p53 reactivation. With a total of 2 patents, his work focuses on innovative methods to enhance cellular functions.

Latest Patents

Quintin Pan's latest patents include groundbreaking inventions that target the reactivation of the p53 protein. The first patent, titled "Oligooxopiperazines for p53 reactivation," describes oligooxopiperazines that comprise two or three oxopiperazine rings. These compounds substantially mimic helix αB of the C-terminal transactivation domain of Hypoxia-Inducible Factor 1α. The patent also discloses methods for utilizing these oligooxopiperazines effectively. The second patent, "Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation," relates to peptidomimetics designed for the same purpose, along with methods of their application.

Career Highlights

Throughout his career, Quintin Pan has worked with prestigious institutions, including New York University and The Ohio State University. His research has contributed to advancements in understanding and manipulating p53, a crucial protein involved in regulating the cell cycle and preventing cancer.

Collaborations

Quintin has collaborated with notable colleagues such as Paramjit S Arora and Anna Mapp. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.

Conclusion

Quintin Pan's work in p53 reactivation exemplifies the importance of innovation in biochemistry. His patents and collaborations highlight his commitment to advancing scientific knowledge and developing new therapeutic strategies.